Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Chronic leukemias

¹Section of Hematology/Oncology, VA Medical Center, Minneapolis, Minnesota.

CA: a Cancer Journal for Clinicians

|November 1, 1994

Summary

This summary is machine-generated.

This review covers chronic leukemias, a group of blood cancers involving mature cell overgrowth. Treatment approaches range from immediate intervention to watchful waiting based on specific disease characteristics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors associated with second-line triplet therapy in routine care in relapsed/refractory multiple myeloma.

Journal of clinical pharmacy and therapeutics·2017

Same author

Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Same author

Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Same author

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).

Transplant infectious disease : an official journal of the Transplantation Society·2014

Same author

The role of body mass index in survival outcome for lymphoma patients: US intergroup experience.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

Same author

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2012

Same journal

Serious mental illness and cancer: A call to action for equitable care.

CA: a cancer journal for clinicians·2026

Same journal

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026

Same journal

Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

CA: a cancer journal for clinicians·2026

Same journal

Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

CA: a cancer journal for clinicians·2026

Same journal

Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

CA: a cancer journal for clinicians·2026

Same journal

Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

CA: a cancer journal for clinicians·2026

See all related articles

Area of Science:

Hematology
Oncology

Background:

Chronic leukemias involve the uncontrolled proliferation of mature hematopoietic cells.
These disorders present with diverse clinical manifestations and prognoses.

Purpose of the Study:

To review the pathology, clinical features, and treatment strategies for chronic leukemias.
To differentiate between chronic leukemia subtypes requiring immediate treatment versus observation.

Main Methods:

Literature review of pathologic features.
Analysis of clinical characteristics.
Evaluation of current treatment modalities.

Main Results:

Chronic leukemias exhibit a wide range of disease behaviors.

Related Experiment Videos

Treatment decisions are highly individualized based on specific leukemia type and patient factors.

Conclusions:

Understanding the heterogeneity of chronic leukemias is crucial for effective management.
Tailored therapeutic strategies, including watchful waiting, are essential for optimal patient outcomes.